300244.SZ
迪安诊断
SZSE · Healthcare · Q 卫生 · CN
CNY 19.82
−4.02%Year over year
Reported trailing growth
- Revenue
- -13.9%
- EBITDA
- —
- EBIT
- +475.1%
- EPS
- +132.5%
- Free cash flow
- +91.1%
- Operating cash flow
- +55.8%
Forward estimates
Based on analyst estimates
- Revenue
- +11.6%
- EBITDA
- +78.0%
- EPS
- +254.3%
Three-year CAGR
- Revenue
- -20.7%
- EBITDA
- -41.6%
- EBIT
- -53.6%
- Net income
- -68.7%
- EPS
- -68.5%
- Free cash flow
- +36.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026